Adapting to change
Health and disease are moving targets: as society evolves and our environment shifts, new health crises emerge. Today we’re facing serious challenges, including the threat of global pandemics like COVID-19, the emergence of antimicrobial resistance (AMR), a rise in the prevalence of cancer and an obesity epidemic.
In response, the field of pharmaceutical science is continuously adapting, with scientists developing novel compounds to address emerging challenges. From targeted cancer treatments to the development of mRNA vaccines during COVID-19, and the launch of weight-loss drugs like Ozempic, new approaches to drug development are transforming how we are affected by disease.
Interdisciplinary intelligence
Modern pharmaceutical science at the intersection between a range of different specialisms.
Professor Sarah Allinson, has co-designed the new range of pharmaceutical science degrees at Lancaster University. She says:
“Pharmaceutical science is becoming increasingly collaborative, bringing in ideas and techniques from other disciplines, such as computer science and data analytics. This means, for example, we can now draw on big data and computational power to speed up – and even automate – many of our processes, ultimately transforming the way we create new drugs.”
A chemical solution
The pharmaceutical science degrees at Lancaster focus on where drugs come from and how they are developed, and include a lot of chemistry alongside core biology modules, enabling students to really get to grips with the chemical make-up of different drugs and understand new drug compounds.
Dr Michael Peach, who designed the chemistry elements of the new courses, says:
“By applying chemistry to biological questions, we can make the right molecules that respond in the right way. It’s a really effective approach to creating real progress”.
Chemistry will have an increasing influence on the future of pharmaceutical science, he says:
“Currently, a relatively small library of molecules is available to develop new drugs, but there’s a lot of exciting work going on at Lancaster to expand that library, and the range of potential drugs that could exist, by developing more complex chemical shapes with the potential to be more targeted.”
A focus for the future
As pharmaceutical science continues to embrace an increasingly interdisciplinary knowledge-base and harness the potential applications of new technology, there will, no doubt, be life-changing advances in targeted and personalised treatments.
Sarah says: “Pharmaceutical science is at the frontier of a new generation of treatments, where, in theory, we could sequence the whole genome of a tumour, for example, identify which proteins are driving its growth, and engineer molecules that fit perfectly within those proteins. I don’t think that level of targeting is too far in the future”.